Pericarditis 发表于 2025-3-23 13:11:07

http://reply.papertrans.cn/1/48/4786/4786-11.png

overrule 发表于 2025-3-23 15:49:32

http://reply.papertrans.cn/1/48/4786/4786-12.png

Enervate 发表于 2025-3-23 18:48:41

Submitted on: 13 September 2003.
Revised on: 03 November 2003.
Accepted on: 19 December 2003.

___________________Cardiovascular Revascularization Medicine

单色 发表于 2025-3-23 23:25:17

Submitted on: 05 November 2023.
Revised on: 15 January 2024.
Accepted on: 17 February 2024.

___________________Cardiovascular Revascularization Medicine

GENUS 发表于 2025-3-24 04:54:26

http://reply.papertrans.cn/1/48/4786/4786-15.png

柔软 发表于 2025-3-24 09:58:50

http://reply.papertrans.cn/1/48/4786/4786-16.png

北京人起源 发表于 2025-3-24 11:21:14

http://reply.papertrans.cn/1/48/4786/4786-17.png

采纳 发表于 2025-3-24 17:32:02

http://reply.papertrans.cn/1/48/4786/4786-18.png

micronutrients 发表于 2025-3-24 21:35:23

http://reply.papertrans.cn/1/48/4786/4786-19.png

哑巴 发表于 2025-3-25 01:42:58

Submitted on: 16 July 2019.
Revised on: 15 October 2019.
Accepted on: 10 November 2019.

___________________Cardiovascular Revascularization Medicine
页: 1 [2] 3 4
查看完整版本: ESCI期刊Cardiovascular Revascularization Medicine 2024/2025影响因子:1.678 (CARDIOVASC REVASCULA) (1553-8389). (CARDIAC & CARD